Amoxicillin

Overall supply risk

US-priority · EO 13944

Formulations

Treats

If blocked

Find alternatives

Supply-chain graph

Click a node to inspect · drag to scroll

Node detail

Risk · the dangerous links

Chokepoints

Where this medicine actually breaks. Not every chokepoint is chemical — a drug can be undeliverable because of its formulation, not its molecule.

Problem space vs solution space

How it's made today vs a proposed US route

The left route is documented from literature and patents. The right route is computationally proposed — a retrosynthesis result constrained to US-sourceable building blocks, not an established commercial route.